JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Boer, J. R.
Right arrow Articles by Vaalburg, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Boer, J. R.
Right arrow Articles by Vaalburg, W.
Journal of Nuclear Medicine Vol. 44 No. 3 341-346
© 2003 by Society of Nuclear Medicine


Clinical Investigations

L-1-11C-Tyrosine PET in Patients with Laryngeal Carcinomas: Comparison of Standardized Uptake Value and Protein Synthesis Rate

Jurjan R. de Boer, MD1, Jan Pruim, MD, PhD2, Bernard F.A.M. van der Laan, MD, PhD1, Tjin H. Que, MD2, Antoon T.M. Willemsen, PhD2, Frans W.J. Albers, MD, PhD1 and Willem Vaalburg, PhD2

1 Departments of Otorhinolaryngology and Head and Neck Surgery, Groningen University Hospital, Groningen, The Netherlands
2 PET Center of Groningen University Hospital, Groningen, The Netherlands

PET with L-1-11C-tyrosine (TYR) can measure and quantify increased protein synthesis in tumor tissue in vivo. For quantification of the protein synthesis rate (PSR), arterial cannulation with repeated blood sampling to obtain the plasma input function and a dynamic TYR PET study to calculate a time–activity curve are necessary. In most PET studies the standardized uptake value (SUV) method is used to quantify tumor activity. The SUV can be calculated without repeated arterial blood sampling and prolonged scanning time, as required for determination of the PSR. The relationship between PSR and SUV is largely unknown and different factors can cause wide variability in the SUV. Therefore, the comparison of the absolute quantification method (PSR) with the SUV method is obligatory to determine the possible use of noninvasive PET in head and neck oncology. Methods: Twenty-four patients with proven squamous cell carcinomas of the larynx (T1–T4) were studied using dynamic TYR PET. The PSRs of tumor and nontumor (background) regions were determined. Four different methods were used to calculate the SUV: uncorrected SUV (SUVBW); and SUVs corrected for body surface area (SUVBSA), for lean body mass (SUVLBM), and for the Quetelet index (SUVQI). Correlations between PSR values and SUVs were calculated. Results: The PSR of all tumors was significantly higher (P < 0.001) than the PSR of nontumor tissue. The correlations of SUVBW, SUVBSA, SUVLBM, and SUVQI with the quantitative values of the PSR were high (r = 0.84–0.90). The best correlation was observed with the SUV based on the LBM (SUVLBM). Conclusion: High correlation between the quantitative values (PSR) and the SUVs offers the possibility to use noninvasive TYR PET for detection and reliable quantification of primary head and neck tumors.

Key Words: L-1-11C-tyrosine • PET • head and neck carcinoma • quantification • protein synthesis rate • standardized uptake value




This article has been cited by other articles:


Home page
JNMHome page
D. C.P. Cobben, B. F.A.M. van der Laan, B. Maas, W. Vaalburg, A. J.H. Suurmeijer, H. J. Hoekstra, P. L. Jager, and P. H. Elsinga
18F-FLT PET for Visualization of Laryngeal Cancer: Comparison with 18F-FDG PET
J. Nucl. Med., February 1, 2004; 45(2): 226 - 231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.